Latest IR information
IR News
- 2026.06.01
- Notice Regarding the Monthly Exercise Status of the 58th and 66th Stock Acquisition Rights (with Exercise Price Adjustment Clause) Issued through Third-Party Allotment
- 2026.05.28
- SymBio Secures European Patent for Use of IV BCV for Adenovirus Infection Strengthening Exclusive Patent Rights for IV BCV in Japan, the U.S., and Europe
- 2026.05.18
- SymBio Establishes Stable Supply Framework for Ultra-High-Sensitive (Pico-Level) Immunochromatography System
- 2026.05.12
- CRADA with NIAID on BCV for Post-Transplant Lymphoproliferative Disorder (PTLD) Extended for Three Years — SymBio to Advance Development of Brincidofovir (BCV) for EBV-Associated Diseases —
- 2026.05.07
- Summary of Consolidated Financial Statements for the Three Months ended March 31, 2026 [Japanese GAAP]